ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

KENNETH BARTHOLOMEW MD

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,098Medicare Part D Prescriptions Filled, Including Refills

Rank: 44 out of 298

$436K Total Retail Price of All Prescriptions

Rank: 46 out of 298

396 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 396 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 396 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 8,176 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
LEVOTHYROXINE SODIUM 496 424 1 1
FUROSEMIDE 335 311 2 5
POTASSIUM CHLORIDE 328 304 3 11
OMEPRAZOLE 317 300 4 3
LISINOPRIL 301 282 5 4
METOPROLOL SUCCINATE 301 263 5 12
SIMVASTATIN 289 270 7 2
HYDROCHLOROTHIAZIDE 268 249 8 13
WARFARIN SODIUM 224 209 9 7
FENTANYL 206 195 S2 10 32
HYDROCODONE-ACETAMINOPHEN 205 153 S3 11 8
AMLODIPINE BESYLATE 195 182 12 6
METOPROLOL TARTRATE 175 170 13 9
ATENOLOL 137 137 14 16
TERAZOSIN HCL 131 131 15 72
ALLOPURINOL 116 112 16 28
CARVEDILOL 110 110 17 23
METFORMIN HCL 109 108 18 10
TRAMADOL HCL 101 101 19 15
SERTRALINE HCL 94 94 20 19
LOSARTAN POTASSIUM 93 92 21 18
DIGOXIN 93 85 21 27
CITALOPRAM HBR 86 86 23 17
NAMENDA 84 84 24 35
MIRTAZAPINE 81 68 25 37
ATORVASTATIN CALCIUM 80 80 26 14
DONEPEZIL HCL 79 79 27 22
DIOVAN 75 64 28 47
CRESTOR 71 70 29 26
DILTIAZEM 24HR CD 64 61 30 74
PROPRANOLOL HCL 63 50 31 85
ENALAPRIL MALEATE 63 50 31 58
KLOR-CON M20 63 63 31 78
LISINOPRIL-HYDROCHLOROTHIAZIDE 61 61 34 30
PREDNISONE 61 46 34 33
TRIAMTERENE-HYDROCHLOROTHIAZID 60 49 36 150
GLIPIZIDE XL 57 57 37 92
RANITIDINE HCL 54 51 38 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 29, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.